Inclusion Criteria:  metastatic prostate cancer recurrent prostate cancer locally advanced prostate cancer "intermediate or high risk" (Gleason >7), operable prostate cancer available FFPE tumor tissue  Exclusion Criteria:  absence of tumor tissue available for analysis